Anand Patel, MD, on the ASAP Trial, Menin Inhibitors, Key Meeting News

By Blood Cancer Talks - Last Updated: July 19, 2023

Dr. Patel, of the University of Chicago, joins the hosts to discuss major updates on leukemia and myeloid malignancies from the 2022 American Society of Hematology Annual Meeting in this episode of “Blood Cancer Talks.”

Dr. Patel and the hosts discuss the phase III ASAP and Dauno-Double trials, as well as the use of menin inhibitors in acute myeloid leukemia, the MOMENTUM study of momelotinib in myelofibrosis, and more.

What are the Risk Factors, Treatment Options for Essential Thrombocythemia?

Dr. Samer Al Hadidi Discusses CAR-T MM Data Presented at the FDA ODAC Meeting

Ayalew Tefferi, MD, on Career Development as a Clinician-Investigator

Angela Dispenzieri, MD, on Managing Newly Diagnosed AL Amyloidosis

ASH 2023 Myeloid Recap With Anand Patel, MD

Editorial Board

Sagar Lonial, MD, FACPEditor-in-Chief | Chief Medical Officer of Winship Cancer Institute at Emory University School of Medicine

Guillermo Garcia-Manero, MDAssociate Editor | Chief, Section of Myelodysplastic Syndromes, The University of Texas MD Anderson Cancer Center

Elias Jabbour, MDExecutive Editor | DB Lane Cancer Research Fund Distinguished Professor in Leukemia Research, MD Anderson Cancer Center

Kami Maddocks, MDAssociate Editor | Professor of Clinical Internal Medicine in the Division of Hematology at The Ohio State University

Thomas Martin, MDAssociate Editor | Clinical Research Director, UCSF Helen Diller Family Comprehensive Cancer Center

Jerald Radich, MDAssociate Editor | Professor in the Clinical Research Division and Kurt Enslein Endowed Chair at Fred Hutch

Laurie Sehn, MD, MPHAssociate Editor | Clinical Professor of Medical Oncology, British Columbia Cancer Centre for Lymphoid Cancer

Anand Patel, MD, on the ASAP Trial, Menin Inhibitors, Key Meeting News

Related